KIR2DL4 and neoplasm: We found no difference in SHP-2 phosphorylation status between KIR2DL4-positive and -negative samples; the cytoplasm was positive for phospho-SHP-2 in all tumor cells (36 of 36 cases [100%], Supplementary Figure 1).